Regulators To Take Close Look At Big Pharma Deals
By Sara Stefanini ( July 21, 2008, 12:00 AM EDT) -- One business day after generic drug giant Teva Pharmaceutical Industries Ltd. announced its plan to buy out rival Barr Pharmaceuticals Inc. for nearly $8 billion, Roche Holdings AG on Monday revealed its own plans to purchase brand pharmaceutical company Genentech Inc. for almost $44 billion. The two deals could draw heavy antitrust scrutiny from regulators in both the U.S. and EU....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.